Dec 31, 2022

Entrada Therapeutics Q4 2022 Earnings Report

EPS
-$0.79
Previous year: -$0.89
-11.2%
Cash and Equivalents
$45.2M
Previous year: $291M
-84.5%
Free Cash Flow
-$28M
Previous year: -$21.9M
+28.1%
Total Assets
$252M
Previous year: $306M
-17.6%

Entrada Therapeutics

Entrada Therapeutics